Skip to content
★ Sign in to follow
LB

Leslie Buttorff

Exactus, Inc.Panacea Life Sciences Holdings, Inc.
Total declarations
45
Company
1
▲ Purchases (39 ops.)
€36k
▼ Sales (0 ops.)
—

Latest filing published 20 Sept 2023 for Panacea Life Sciences Holdings, INC., €4,424.

Filing timeline

BuySale
Leslie Buttorff

Insider track record

Disclosed buys
39
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-76.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Leslie Buttorff: trading record in brief

All filings by Leslie Buttorff on record concern Panacea Life Sciences Holdings, Inc. In total, 45 filings cover trades dated from 30 June 2021 to 18 September 2023.

Every open-market trade on record is a purchase: 39 purchases worth €36k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants. 2023 to date brings 17 purchases and no sales.

A typical purchase (the median) is worth €392. On 3 out of 39 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 20 September 2023 came the latest disclosure, an open-market purchase for €4,424 in Panacea Life Sciences Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Leslie Buttorff

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations